Kaleida Capital is a venture capital firm investing in neurotechnology, AI, and cognitive systems redefining the future of human performance.
Founded by Stanford-trained neuroengineer and investor Dr. Ariane Tom, Kaleida Capital was built to identify and back the next generation of cognitive infrastructure — from neural interfaces and brain data platforms to adaptive AI and resilience tools. We invest early, lead with technical rigor, and partner with visionary teams shaping how minds and machines interact.
Kaleida targets early-stage investments in U.S.-based founders with research-driven IP, valuation discipline, and long-term category potential. Portfolio companies include Science, Paradromics, Anthropic, Resonant Link Medical, and Manifest Technologies (acquired).
With experience spanning brain-machine interfaces, computational neuroscience, patent law, and early-stage venture, Kaleida is uniquely positioned to bring deep diligence and domain fluency to an emerging, high-impact frontier.
Company Details
- Employees
- 2
- Founded
- -
- Address
- San Diego , Ca, Us
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.kaleidacapital.com
- HQ
- San Diego , CA
Kaleida Capital Questions
Kaleida Capital's website is http://www.kaleidacapital.com
Kaleida Capital's LinkedIn profile is https://www.linkedin.com/company/kaleidacapital
Kaleida Capital has
2 employees.
View email and phone details for 2
employees at Kaleida Capital.
Kaleida Capital's industry is
Venture Capital and Private Equity Principals
Kaleida Capital's top competitors are
Arrowpoint Labs,
Medical Excellence Capital, Llc,
Insight Partners,
Paradromics,
Science,
Anzu Partners,
Cytohub Inc.,
Phase Two Ventures,
Mithradote Bio, Inc.,
Beacon Biosignals.
Kaleida Capital's categories are Venture Capital and Private Equity Principals
Kaleida Capital's founding year is 2022
